Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Dr.Reddy’s recall Sirolimus tablets fo

Dr.Reddy’s (DRL) is recalling 1176 bottles of Sirolimus 1mg tablets (NDC 55111-653-01) in US for

Eudra GMDP lists Everest Organics and Ak

Everest Organics Ltd (Telangana, India) was issued a GMP Non-Compliance Report with recommendation to suspend

CDSCO Spurious Drug Alert for Instgra, T

CDSCO has issued spurious drug alert for five medicinal products. The spurious drug alert includes

Eugia USFDA 483 Cites Inadequate Contain

Aurobindo arm, Eugia Pharma Specialities facility at Bhiwadi, Rajasthan was issued USFDA 483 with seven

Zydus Vadodara USFDA 483 cites Contamina

USFDA inspection of Zydus Life sciences, Vadodara facility resulted in USFDA 483 with 10 observations.

CDSCO to take Charge of Export NOCs for

The Drug Controller General of India (DCGI) has notified that effective from May 15, 2024, the issuance of

WHO Alert on Falsified Dow Propylene gly

WHO has issued an alert on falsified Propylene glycol bearing name of Dow detected in

USFDA 483 to Sun Pharma points to lack o

The USFDA 483 issued to Sun Pharma, Dadra unit in India (FEI 3004561553) published by

J&J cough syrup contamination with D

J&Js paediatric cough syrup Benylin is being recalled in several African countries following detection of

EDQM revises guideline for Content of Do

The revised EDQM guideline “Content of the dossier for chemical purity and microbiological quality of